StemCyte India Therapeutics Pvt. Ltd. (USA based company): World class stems cell banking. It was born on the 1st Vibrant Gujarat Summit by Honorable Prime Minister Shri Narendrabhai Modi. It was established in 2008 and it is a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Ltd. and Cadila Pharmaceuticals Ltd. We have patented Plasma depletion technology design to deliver maximum number of high quality stem cell. Ensures cell recovery up to 99.96% - unmatched in industry. StemCyte is the world leader in Umbilical cord blood transplant. It is the only company with the experience of treating 58 Hematopoetic blood disorders like Thelassemia, CGD, HLH, Fanconi Anemia, Immune Defiency Disorder and Infantile etc. • We have facilitated as many as 2000 transplant across 315 centers in 38 countries across 6 continents. • The company is backed by a world-class doctor fraternity within the Apollo group. • We have 75,000 units in Public & Private inventories across the globe. • StemCyte offers a complete stem cell solution from banking to application. • We have a trained transplant coordination team, together with trained staff at all touch points, works to achieve best possible outcomes. • International accreditation, FDA and AABB approved certifications and licenses that endorse commitment to quality. • We adopt a unique “hybrid+” model involving public banking, private banking, therapeutic application and clinical trials.

StemCyte India Therapeutics Pvt. Ltd. (USA based company): World class stems cell banking. It was born on the 1st Vibrant Gujarat Summit by Honorable Prime Minister Shri Narendrabhai Modi. It was established in 2008 and it is a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Ltd. and Cadila Pharmaceuticals Ltd. We have patented Plasma depletion technology design to deliver maximum number of high quality stem cell. Ensures cell recovery up to 99.96% - unmatched in industry. StemCyte is the world leader in Umbilical cord blood transplant. It is the only company with the experience of treating 58 Hematopoetic blood disorders like Thelassemia, CGD, HLH, Fanconi Anemia, Immune Defiency Disorder and Infantile etc. • We have facilitated as many as 2000 transplant across 315 centers in 38 countries across 6 continents. • The company is backed by a world-class doctor fraternity within the Apollo group. • We have 75,000 units in Public & Private inventories across the globe. • StemCyte offers a complete stem cell solution from banking to application. • We have a trained transplant coordination team, together with trained staff at all touch points, works to achieve best possible outcomes. • International accreditation, FDA and AABB approved certifications and licenses that endorse commitment to quality. • We adopt a unique “hybrid+” model involving public banking, private banking, therapeutic application and clinical trials.